Dr Reddys Laboratories Ltd

DRREDDY · NSEHealthcareNSE session: Live

₹1,161.00

-₹11 (-0.94%) today

Delayed market data

Practice terminal

Price

Delayed market data

loading…

Key metrics

Via screener.in

30 June 2026 · Fundamentals via screener.in · fetched 9 August 2026 (https://www.screener.in/company/DRREDDY/). Figures are as published there; anything not published is shown as unavailable.

Market cap

₹97,824 Cr

P/E ratio

148.00

P/B ratio

—

Dividend yield

0.68%

52W high

₹1,415.00

52W low

₹1,080.00

Volume

15,78,229

Beta

—

Factual checks

Via screener.in

Statements of what the filings say. There is no score, grade or pass/fail here — reading these numbers is your call.

30 June 2026 · Fundamentals via screener.in · fetched 9 August 2026 (https://www.screener.in/company/DRREDDY/). Figures are as published there; anything not published is shown as unavailable.

Return on capital employed

12.1% as published by screener.in for the period ended 30 June 2026.

Return on equity

10.2% as published by screener.in for the period ended 30 June 2026.

Dividend yield

0.68% as published by screener.in for the period ended 30 June 2026.

Price to earnings

148× as published by screener.in for the period ended 30 June 2026.

Book value per share

₹376 as published by screener.in for the period ended 30 June 2026.

Face value

₹1 as published by screener.in for the period ended 30 June 2026.

Return on equity

10.20%

Debt to equity

—

About the company

Via screener.in

30 June 2026 · Fundamentals via screener.in · fetched 9 August 2026 (https://www.screener.in/company/DRREDDY/). Figures are as published there; anything not published is shown as unavailable.

Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.

Founded

Headquarters

IndustryPharmaceuticals

Educational only · not investment advice. Virtual money · educational only · not investment advice. Market data is delayed and indicative. Investments in securities markets are subject to market risks. Operating entity and registration details: see Terms & Disclaimer.